Dr. Diana van Stijn, MD Ph.D
Biography
Diana van Stijn M.D. Ph.D is a pediatric resident who works at the Amsterdam UMC, The Netherlands. Dr. van Stijn is the co-founder and Chief Medical Officer of Lapsi Health, a Digital Biomarker development company located in The Netherlands. She is the lead of Innovation and Medical strategy of the company, creating new digital biomarkers that will reshape clinical decision making, support patient empowerment and enable proper digital clinical research.
She is also a leading expert on digital therapeutics (DTx) and is a faculty member of the DTxcellence program, a first of its kind digital education initiative for medical and non-medical professionals that want to learn Digital Therapeutics and other important concepts of Digital Health.
Dr. van Stijn received her Ph.D. in Pediatrics investigating Kawasaki disease and the COVID-related new emerging pediatric disease called MIS-C. Dr. van Stijn believes in the democratization of healthcare and the empowerment of women in Healthcare and Health-Tech.
Click image for Dr. van Stijn's LinkedIn page